News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
91,376 Results
Type
Article (6729)
Company Profile (41)
Press Release (84606)
Section
Business (27805)
Career Advice (126)
Deals (4002)
Drug Delivery (32)
Drug Development (14136)
Employer Resources (12)
FDA (2855)
Job Trends (2120)
News (49340)
Policy (6007)
Tag
Academia (423)
Allergies (21)
Alliances (8984)
Alzheimer's disease (237)
Antibody-drug conjugate (ADC) (25)
Approvals (2837)
Artificial intelligence (21)
Bankruptcy (18)
Best Places to Work (1788)
BIOSECURE Act (15)
Biosimilars (64)
Biotechnology (29)
Breast cancer (22)
Cancer (231)
Career advice (109)
Cell therapy (49)
Clinical research (11203)
Collaboration (90)
Compensation (17)
COVID-19 (529)
C-suite (25)
Data (231)
Diabetes (20)
Diagnostics (527)
Drug pricing (19)
Earnings (9229)
Events (11563)
Executive appointments (49)
FDA (3009)
Funding (68)
Gene therapy (52)
GLP-1 (96)
Government (1292)
Healthcare (1967)
Immunology and inflammation (19)
Infectious disease (548)
Inflammatory bowel disease (40)
IPO (1826)
Job creations (389)
Job search strategy (107)
Layoffs (49)
Legal (560)
Lung cancer (54)
Lymphoma (13)
Manufacturing (71)
Medical device (1193)
Medtech (1194)
Mergers & acquisitions (2220)
Metabolic disorders (45)
Neuroscience (283)
NextGen Class of 2024 (704)
Non-profit (348)
Northern California (282)
Obesity (16)
Opinion (40)
Patents (14)
Peanut (18)
People (7856)
Phase I (3675)
Phase II (4680)
Phase III (4092)
Pipeline (134)
Policy (27)
Postmarket research (293)
Preclinical (1442)
Press Release (66)
Radiopharmaceuticals (35)
Rare diseases (38)
Real estate (914)
Regulatory (4565)
Research institute (390)
Southern California (293)
Startups (575)
United States (2522)
Vaccines (141)
Date
Last 7 days (113)
Last 30 days (671)
Last 365 days (6624)
2024 (6088)
2023 (6998)
2022 (9175)
2021 (9549)
2020 (8250)
2019 (5899)
2018 (4586)
2017 (5102)
2016 (4663)
2015 (5320)
2014 (3748)
2013 (2911)
2012 (2999)
2011 (3155)
2010 (2581)
Location
Africa (91)
Asia (7439)
Australia (871)
California (659)
Canada (158)
China (93)
Colorado (25)
Delaware (16)
Europe (13612)
Florida (75)
Illinois (31)
Indiana (25)
Maryland (231)
Massachusetts (438)
Minnesota (36)
New Jersey (280)
New York (182)
North Carolina (150)
Northern California (282)
Ohio (28)
Pennsylvania (121)
South America (134)
Southern California (293)
Texas (79)
Washington State (56)
91,376 Results for "samsung biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Samsung Biologics signs manufacturing deal with European pharmaceutical company
November 20, 2024
·
3 min read
Press Releases
Samsung Biologics reports third quarter 2024 financial results
October 23, 2024
·
4 min read
Business
Samsung Biologics Reports First Quarter 2024 Financial Results
Samsung Biologics, a global contract development and manufacturing organization, announced financial results for the first quarter of fiscal year 2024.
April 24, 2024
·
4 min read
Press Releases
Samsung Biologics signs largest manufacturing deal with Asia-based pharmaceutical company
October 22, 2024
·
3 min read
Press Releases
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
October 14, 2024
·
3 min read
Deals
Samsung Bio Nabs $1B Manufacturing Contract With Undisclosed US Pharma
Samsung Biologics announced Tuesday it has signed its largest contract ever—a $1.06 billion manufacturing deal with an unnamed pharmaceutical company headquartered in the U.S.
July 2, 2024
·
2 min read
·
Tristan Manalac
Policy
FDA Approves PYZCHIVA® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar to Stelara
Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration has approved the Biologics License Application for PYZCHIVA® subcutaneous injection and intravenous infusion as a biosimilar to Stelara.
July 1, 2024
·
10 min read
Samsung Biologics awarded Leadership status by CDP for climate action efforts
Samsung Biologics, a global contract development and manufacturing organization, announced that it has received the Leadership status and A- rating from the Carbon Disclosure Project.
February 13, 2024
·
2 min read
Business
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing
Samsung Biologics today announced it has signed a partnership agreement with LegoChem Biosciences (KOSDAQ: 141080), a biotech company pioneering the research and development of antibody-drug conjugate (ADC) programs.
February 7, 2024
·
3 min read
Business
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2023 Financial Results
Samsung Biologics announced robust financial results for the fourth quarter and fiscal year 2023.
January 24, 2024
·
5 min read
1 of 9,138
Next
